KMWorld CRM Media Streaming Media Faulkner Speech Technology Unisphere/DBTA
Other ITI Websites
American Library Directory Boardwalk Empire Database Trends and Applications DestinationCRM EContentMag Faulkner Information Services Fulltext Sources Online InfoToday Europe Internet@Schools Intranets Today KMWorld Library Resource Literary Market Place OnlineVideo.net Plexus Publishing Smart Customer Service Speech Technology Streaming Media Streaming Media Europe Streaming Media Producer Unisphere Research



News & Events > NewsBreaks
 



Back Index Forward
Twitter RSS Feed
Weekly News Digest

December 10, 2012 — In addition to this week's NewsBreaks article and the monthly NewsLink Spotlight, Information Today, Inc. (ITI) offers Weekly News Digests that feature recent product news and company announcements. Watch for additional coverage to appear in the next print issue of Information Today. For other up-to-the-minute news, check out ITI’s Twitter account: @ITINewsBreaks.

CLICK HERE to view more Weekly News Digest items.

Thomson Reuters Announces Cortellis for Clinical Trials Intelligence

The IP & Science business of Thomson Reuters announced a preview of its newest intelligence solution, Thomson Reuters Cortellis for Clinical Trials Intelligence. Scheduled for release in early 2013, this capability will provide drug development and clinical professionals with the critical information necessary to evaluate market opportunities, identify potential barriers, and establish informed decisions about clinical trial design and operations.

Cortellis for Clinical Trials Intelligence is the latest information solution offered through Thomson Reuters Cortellis, the company’s Life Sciences information delivery platform. It has the broadest remit of any clinical trials database including a 45-year history of clinical outcomes, as well as the latest market competitive activity from established and emerging markets such as China, India, and Brazil. It is the only solution that enables a customer to integrate their proprietary research data with comprehensive clinical trials protocols and outcomes, drug pipeline, biomarker, regulatory, financial, and patent information from Thomson Reuters. With its integrated analytics tools and visualizations, users will have greater opportunities to maximize the value of clinical trial content to inform internal strategy and decision-making.

“Cortellis for Clinical Trials Intelligence provides comprehensive clinical trial protocols and outcomes with global reach and integrates with other key intelligence areas—such as patents and literature—to allow for the broadest possible perspectives and actionable insights,” said Jon Brett-Harris, executive vice president at Thomson Reuters. “However, it is not just an information web portal. We are also providing multiple delivery options, such as dynamic real-time visualizations, iPad support and application programming interfaces to assist our customers in integrating it with their existing knowledge platforms and workflow solutions.”

Source: Thomson Reuters



Send correspondence concerning the Weekly News Digest to NewsBreaks Editor Brandi Scardilli

Related Articles

11/14/2011New Pharmaceutical Information Tool Coming From Thomson Reuters—Cortellis
7/2/2013Thomson Reuters Offers Clinical Trial Intelligence Solutions


Comments Add A Comment

              Back to top